Concepedia

Hayley M. Jones

HM

Statistics

Publications

6

Citations

315

H-Index

6

Active since

2013

Affiliations

LifeArc(Current)

Hayley M. Jones is an author at LifeArc specializing in drug discovery, enzyme inhibition, and plasmodium falciparum.

Publications per year

2013–2015

6

Publications

6

Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance

Ewan M. McNeil, Katy R. Astell, Ann‐Marie Ritchie et al. · DNA repair · 2015 · 77 citations · Full text

, , +9

Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development

Judith L. Green, Robert W. Moon, David Whalley et al. · Antimicrobial Agents and Chemotherapy · 2015 · 57 citations · Full text

, , +17

Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)

Timothy M. Chapman, Simon A. Osborne, Nathalie Bouloc et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 54 citations · Full text

, , +17

Optimization of an Imidazopyridazine Series of Inhibitors of <i>Plasmodium falciparum</i> Calcium-Dependent Protein Kinase 1 (<i>Pf</i>CDPK1)

Timothy M. Chapman, Simon A. Osborne, Claire Wallace et al. · Journal of Medicinal Chemistry · 2014 · 50 citations · Full text

, , +17

Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues

Jonathan M. Large, Simon A. Osborne, Ela Smiljanic-Hurley et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 40 citations · Full text

, , +15

1–5 of 6